Human Genome Epidemiology Literature Finder
|
Records 1 - 5 (of 5 Records) |
| Query Trace: Dystonia and DRD2[original query] |
|---|
| Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia. Molecular psychiatry 2002 7 (7): 695-705. Kaiser R, Tremblay P-B, Klufmöller F, Roots I, Brockmöller |
| Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms. European journal of clinical pharmacology 2007 Mar 63 (3): 233-41. Güzey Cüneyt, Scordo Maria Gabriella, Spina Edoardo, Landsem Veslemøy Malm, Spigset Ol |
| Candidate gene-based association study of antipsychotic-induced movement disorders in long-stay psychiatric patients: a prospective study. PloS one 2012 7 (5): e36561. Bakker P Roberto, Bakker Egbert, Amin Najaf, van Duijn Cornelia M, van Os Jim, van Harten Peter |
| Dopamine DRD2 polymorphism (DRD2/ANNK1-Taq1A) is not a significant risk factor in writer's cramp. Journal of neurogenetics 2016 Oct 1-4. Zeuner Kirsten E, Acewicz Albert, Knutzen Arne, Dressler Dirk, Lohmann Katja, Witt Karst |
| Clinical implications of genetic polymorphisms in blepharospasm. Experimental and therapeutic medicine 2024 7 28 (2): 332. Jeong-Kyeong Jang, Min-Jung Kwon, Nam-Keun Kim, Helen L |
- Page last reviewed:Feb 1, 2024
- Content source: